Modern Pathology

Article	Citations
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies	646
COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City	349
A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression	332
In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19	241
SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers	190
Digital pathology and artificial intelligence in translational medicine and clinical practice	173
Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data	172
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience	170
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia	131
Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel	115
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia	108
Validation of a digital pathology system including remote review during the COVID-19 pandemic	104
Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies	100
Development of a prognostic model for mortality in COVID-19 infection using machine learning	99
Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status	97
Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer	92
Poorly differentiated thyroid carcinoma of childhood and adolescence: a distinct entity characterized by DICER1 mutations	85
Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19	83
DNAJB1-PRKACA fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma	83
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer	82
Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review	78
Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists	77
A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation	76
Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets	76
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases	74

Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)	71
Lung neuroendocrine neoplasms: recent progress and persistent challenges	69
Quality control stress test for deep learning-based diagnostic model in digital pathology	69
Spitz melanoma is a distinct subset of spitzoid melanoma	62
DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma	62
Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning	61
Mapping the binding sites of antibodies utilized in programmed cell death ligand-1 predictive immunohistochemical assays for use with immuno-oncology therapies	59
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer	59
Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)	59
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer	59
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer	58
Retained mismatch repair protein expression occurs in approximately 6% of microsatellite instability-high cancers and is associated with missense mutations in mismatch repair genes	58
Counting mitoses: SI(ze) matters!	58
Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection	56
Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization	55
NTRK insights: best practices for pathologists	53
Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases	53
NTRK3 overexpression in undifferentiated sarcomas with YWHAE and BCOR genetic alterations	52
Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions	51
NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas—a study of 4569 cases	50
Clinicopathological significance of deficient DNA mismatch repair and MLH1 promoter methylation in endometrioid endometrial carcinoma	49
HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles	48
An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy	48
Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointesti	48
ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217	47
Three-dimensional visualization of cleared human pancreas cancer reveals that sustained epithelial-to-mesenchymal transition is not required for venous invasion	45
EWSR1/FUS–CREB fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities	45
PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy	45
Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions	44
Liver biopsy findings in patients on immune checkpoint inhibitors	43
The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression	43
Diffuse trophoblast damage is the hallmark of SARS-CoV-2-associated fetal demise	43
Recurrent KRAS mutations in papillary renal neoplasm with reverse polarity	43
Four major patterns of placental injury: a stepwise guide for understanding and implementing the 2016 Amsterdam consensus	43
Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal carcinoma: a multicenter clinicopathologic study	42
Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma	42
Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification	42
Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America	41
Integrating digital pathology into clinical practice	41
Effect of decalcification protocols on immunohistochemistry and molecular analyses of bone samples	41
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer	41
Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases	40
Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls	40
Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma	39
Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome	39
Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas	39
Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer	39
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime	37
Genomic profiling of primary and recurrent adult granulosa cell tumors of the ovary	37
DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor	36

T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics	36
Melanocytic tumors with MAP3K8 fusions: report of 33 cases with morphological-genetic correlations	36
Fibroepithelial lesions revisited: implications for diagnosis and management	36
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker	36
Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome	36
Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations	36
Tumor spread through air spaces (STAS): prognostic significance of grading in non-small cell lung cancer	35
Prognostic value of macrophage polarization markers in epithelial neoplasms and melanoma. A systematic review and meta-analysis	35
Interpretable multimodal deep learning for real-time pan-tissue pan-disease pathology search on social media	35
Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity—a comparative study with papillary renal cell carcinoma	35
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial	34
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability	34
Infantile inflammatory myofibroblastic tumors: clinicopathological and molecular characterization of 12 cases	33
A machine learning algorithm for simulating immunohistochemistry: development of SOX10 virtual IHC and evaluation on primarily melanocytic neoplasms	33
Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression	33
A multicenter analysis of genomic profiles and PD-L1 expression of primary lymphoepithelioma-like carcinoma of the lung	33
PIK3CA mutations in lipomatosis of nerve with or without nerve territory overgrowth	32
Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer	32
DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology	32
Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma	32
Molecular characterization of diffuse malignant peritoneal mesothelioma	32
Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney	31
Genomic landscape of endometrial carcinomas of no specific molecular profile	31
Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity	31
Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1	31
PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma	31
Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes	31
Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescence	30
Identification of nodal micrometastasis in colorectal cancer using deep learning on annotation-free whole-slide images	30
Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients	30
Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix	30
Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features	30
Recurrent and novel USP6 fusions in cranial fasciitis identified by targeted RNA sequencing	29
Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas	28
INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma	28
Pathologic separation of idiopathic pulmonary fibrosis from fibrotic hypersensitivity pneumonitis	28
Undifferentiated round cell sarcoma with BCOR internal tandem duplications (ITD) or YWHAE fusions: a clinicopathologic and molecular study	28
Deep convolutional neural network-based classification of cancer cells on cytological pleural effusion images	28
YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases	28
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy	28
Assessment of individual tumor buds using keratin immunohistochemistry: moderate interobserver agreement suggests a role for machine learning	28
Pathological assessment of endoscopic resections of the gastrointestinal tract: a comprehensive clinicopathologic review	28
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome	28
Varying practices in tumor regression grading of gastrointestinal carcinomas after neoadjuvant therapy: results of an international survey	28
Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes	27
Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma	27
Melanomas with activating RAF1 fusions: clinical, histopathologic, and molecular profiles	27
Recurrent MEIS1-NCOA2/1 fusions in a subset of low-grade spindle cell sarcomas frequently involving the genitourinary and gynecologic tracts	27
“Inflammatory Leiomyosarcoma” and “Histiocyte-rich Rhabdomyoblastic Tumor”: a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as “Inflammat	27
EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma	27
Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon	27
IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis	27
Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression	27
The healthcare value of the Magee Decision Algorithm™: use of Magee Equations™ and mitosis score to safely forgo molecular testing in breast cancer	26
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy	26
Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile	26
Looking past PD-L1: expression of immune checkpoint TIM-3 and its ligand galectin-9 in cervical and vulvar squamous neoplasia	26
High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities	26
Artificial intelligence-assisted system for precision diagnosis of PD-L1 expression in non-small cell lung cancer	26
Pleural mesothelioma classification—update and challenges	26
A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies	26
Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas	26
E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements	26
Differentiated exophytic vulvar intraepithelial lesion: Clinicopathologic and molecular analysis documenting its relationship with verrucous carcinoma of the vulva	25
Novel GATA6-FOXO1 fusions in a subset of epithelioid hemangioma	25
Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study	25
Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup	25
Lipoblastomas presenting in older children and adults: analysis of 22 cases with identification of novel PLAG1 fusion partners	25
Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types	25
Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups	25
Multiregion exome sequencing of ovarian immature teratomas reveals 2N near-diploid genomes, paucity of somatic mutations, and extensive allelic imbalances shared across mature, immature, and dissemina	25
Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients	25
MicroRNA signatures associated with lymph node metastasis in intramucosal gastric cancer	25
Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations	25
Comparison of continuous measures across diagnostic PD-L1 assays in non-small cell lung cancer using automated image analysis	25
Problematic breast tumors reassessed in light of novel molecular data	25
A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma	25
Two types of primary mucinous ovarian tumors can be distinguished based on their origin	25
EWSR1-PATZ1-rearranged sarcoma: a report of nine cases of spindle and round cell neoplasms with predilection for thoracoabdominal soft tissues and frequent expression of neural and skeletal muscle mar	24
B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma	24

Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I–III, non-small cell lung car	24
Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma	24
Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations	24
Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases	24
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features	24
ARID1A mutations and expression loss in non-small cell lung carcinomas: clinicopathologic and molecular analysis	24
Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study	24
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1	24
Myxoid pleomorphic liposarcoma—a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcom	24
Reproducibility of scoring criteria for HER2 immunohistochemistry in endometrial serous carcinoma: a multi-institutional interobserver agreement study	23
TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas	23
Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship	23
AKT1 internal tandem duplications and point mutations are the genetic hallmarks of sclerosing pneumocytoma	23
The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go	23
Female adnexal tumors of probable Wolffian origin: morphological, immunohistochemical, and molecular analysis of 15 cases	23
A novel group of HPV-related adenocarcinomas of the lower anogenital tract (vagina, vulva, and anorectum) in women and men resembling HPV-related endocervical adenocarcinomas	23
Frequent loss of mutation-specific mismatch repair protein expression in nonneoplastic endometrium of Lynch syndrome patients	23
Pleuropulmonary blastoma-like peritoneal sarcoma: a newly described malignancy associated with biallelic DICER1 pathogenic variation	23
PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells	22
Clinical, morphologic, and genomic findings in ROS1 fusion Spitz neoplasms	22
Myositis ossificans-like soft tissue aneurysmal bone cyst: a clinical, radiological, and pathological study of seven cases with COL1A1-USP6 fusion and a novel ANGPTL2-USP6 fusion	22
Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1–KMT2A–YAP1 and VIM–KMT2A fusions	22
A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological response	22
RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas	22
Papillary neoplasms of the breast—reviewing the spectrum	22
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma	22
Histologic grading of breast carcinoma: a multi-institution study of interobserver variation using virtual microscopy	22
HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva	21
Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations	21
Detection and assessment of capsular invasion, vascular invasion and lymph node metastasis volume in thyroid carcinoma using microCT scanning of paraffin tissue blocks (3D whole block imaging): a proo	21
Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma	21
A new tool for technical standardization of the Ki67 immunohistochemical assay	21
Assessment of deep learning assistance for the pathological diagnosis of gastric cancer	21
Comparison of solid tissue sequencing and liquid biopsy accuracy in identification of clinically relevant gene mutations and rearrangements in lung adenocarcinomas	21
NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis	21
Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung—a single-center analysis of 354 cases	21
Recommendations on compiling test datasets for evaluating artificial intelligence solutions in pathology	21
An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes	21
A novel prognostic two-gene signature for triple negative breast cancer	21
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses	21
Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma	20
DICER1-associated sarcomas: towards a unified nomenclature	20
MIXTURE of human expertise and deep learning—developing an explainable model for predicting pathological diagnosis and survival in patients with interstitial lung disease	20
Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations	20
Prognostic value of mitotic checkpoint protein BUB3, cyclin B1, and pituitary tumor-transforming 1 expression in prostate cancer	20
Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes	20
Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms	20
Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution	20
Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma	20
Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases	20
Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas	20
Endogenous APOBEC3B overexpression characterizes HPV-positive and HPV-negative oral epithelial dysplasias and head and neck cancers	20
N-Glycan profiling of lung adenocarcinoma in patients at different stages of disease	20
Clinical, histopathologic, and immunoarchitectural features of dermatopathic lymphadenopathy: an update	19
Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies	19
Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors	19
Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma	19
Myeloid/lymphoid neoplasms with FLT3 rearrangement	19
Chromosomal and molecular pathway alterations in the neuroendocrine carcinoma and adenocarcinoma components of gastric mixed neuroendocrine–nonneuroendocrine neoplasm	19
Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas	19
Prediction of non-muscle invasive bladder cancer recurrence using machine learning of quantitative nuclear features	19
Testosterone therapy and breast histopathological features in transgender individuals	19
Genomic profiling of pleomorphic and florid lobular carcinoma in situ reveals highly recurrent ERBB2 and ERRB3 alterations	18
Minimalist approaches to cancer tissue-of-origin classification by DNA methylation	18
Diffuse expression of MUC6 defines a distinct clinicopathological subset of pulmonary invasive mucinous adenocarcinoma	18
PAX8 expression and TERT promoter mutations in the nested variant of urothelial carcinoma: a clinicopathologic study with immunohistochemical and molecular correlates	18
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study	18
Nodular fasciitis: a comprehensive, time-correlated investigation of 17 cases	18
Analysis of the immune checkpoint V-domain Ig-containing suppressor of T-cell activation (VISTA) in endometrial cancer	18
The clinicopathologic spectrum and genomic landscape of de-/trans-differentiated melanoma	18
Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease	18
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas	18
RAF1 rearrangements are common in pancreatic acinar cell carcinomas	18
Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutation	18
p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patterns	17
The Role of Artificial Intelligence in Accurate Interpretation of HER2 Immunohistochemical Scores 0 and 1+ in Breast Cancer	17
Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancer	17
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry	17
Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing	17
Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study	17
Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma	17
Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to s	17
Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas	17
A novel next generation sequencing approach to improve sarcoma diagnosis	17
Oncocytic renal neoplasms with diffuse keratin 7 immunohistochemistry harbor frequent alterations in the mammalian target of rapamycin pathway	17
KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy	17
TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma	17
Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis	17
Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features	17
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study	17
Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tract	17
Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma	17
Hybrid schwannoma–perineurioma frequently harbors VGLL3 rearrangement	17
Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine	17
Characterization of novel genetic alterations in salivary gland secretory carcinoma	16